Document is current
Any future updates will be listed below
-
Authors
Lefferts, Adam R.
Regner, Emilie H.
Stahly, Andrew
O’Rourke, Becky
Gerich, Mark E.
Fennimore, Blair P.
Scott, Frank I.
Freeman, Alison E.
Jones, Ken
Kuhn, Kristine A. https://orcid.org/0000-0002-6900-4195
-
Funding
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32 AR007534)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32 AR007534)
National Institute of Allergy and Infectious Diseases (U01 AI101990)
Boettcher Foundation (Webb-Waring Biomedical Research Award)
Spondylitis Association of America (Bruckel Early Investigator Award in AxSpa)
Pfizer (Global Medical Grant)
- License Information
-
More Information
Article History
Received: 29 December 2020
Accepted: 12 May 2021
First Online: 22 May 2021
Declarations
:
: This study was conducted according to the principles within the Declaration of Helsinki. All study procedures were approved by the Colorado Multiple Institutional Review Board (protocol #14-1507). All subjects provided written informed consent and authorization for release of personal health information. An independent safety officer (Lisa Davis, MD) was assigned and met annually with the investigators to conduct safety reviews.
: Not applicable.
: Our work was supported, in part, through a Global Medical Grant by Pfizer awarded to KAK. However, Pfizer had no role in the design of the study; collection, analysis, and interpretation of the data; or writing of the manuscript.
